Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Almost 200 cases of unexplained acute hepatitis reported in children -ECDC

Published 26/04/2022, 14:14
Updated 26/04/2022, 14:15
© Reuters. FILE PHOTO: A logo is pictured at the World Health Organization (WHO) building in Geneva, Switzerland, February 2, 2020. Picture taken February 2, 2020. REUTERS/Denis Balibouse//File Photo

(Reuters) - Around 190 unexplained cases of severe hepatitis have been reported in children around the world, the European Centre for Disease Prevention and Control said on Tuesday.

The outbreak was first reported this month in Britain - which has registered 111 cases, mostly in children under 10 - and has since been identified in at least 12 countries worldwide.

Some 40 cases have been recorded in the European Union and European Economic Area, ECDC director Andrea Ammon told reporters in a virtual briefing.

The United States and Israel have also seen cases.

The ECDC is investigating alongside national authorities and the World Health Organization. Severe hepatitis, or inflammation of the liver, is rare in otherwise healthy children.

Unusually, the new cases do not feature the viruses typically responsible for acute liver inflammation – hepatitis A, B, C, D and E.

According to the WHO, 17 children have needed liver transplants as a result of the recent cases, and one has died.

Ammon said the investigations so far pointed towards a link to infection with an adenovirus, a family of common viruses that can cause flu-like or gastrointestinal symptoms.

She said a theory that COVID-19 lockdowns may have weakened children's immunity, because they were less exposed to common pathogens while in isolation, was one of several being considered.

Scientists are also investigating whether the adenovirus involved has mutated, or is acting in tandem with another infection, possibly COVID-19. A toxin could also be responsible, but this is thought less likely due to the geographical spread of the cases reported.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Any link with COVID-19 vaccination has been ruled out.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.